| Medicines and Healthcare Products Regulatory Agency |
MHRA Press Release, Jul 21, 2006
Black cohosh (Cimicifuga racemosa) - risk of liver problems
July 2006
Traditionally, black cohosh (Cimicifuga racemosa) has been used to treat a
variety of conditions including rheumatism, rheumatoid arthritis, joint aches,
muscle pain and neuralgia. Now it is most commonly used to treat menopausal
symptoms such as hot flushes, night sweats, joint aches, headaches, insomnia,
palpitations.
As of 31 May 2006, 31 reports of suspected adverse reactions associated with
black cohosh have been received through the Yellow Card Scheme. Of these, 22
have been reports of liver reactions - ranging in severity from abnormal liver
function (15 people) to various forms of hepatitis (six people) including one
case of liver failure. Generally, the individuals recovered or were
recovering after stopping black cohosh.
Original concerns about potential risks associated with the use of
black cohosh were raised in 2004 when a number of reports of hepatotoxicity
(liver disease) were reported and MHRA issued an alert to health
professionals.
Following further reports of suspected adverse reactions, the Commission on
Human Medicines and the Herbal Medicines Advisory Committee reviewed the
available data on liver reactions with black cohosh and, subsequently, advised
that these data support a causal association between black cohosh and the risk
of liver disorders.
Warnings are being added to the labels for all black cohosh products and
the MHRA is working with the relevant marketing authorisation holders and
the herbal sector to ensure people are fully informed about this potential
risk.
There are many signs and symptoms of liver disease. These
include jaundice (yellowing of the skin or whites of the eyes), dark urine,
nausea, vomiting, unusual tiredness, weakness, stomach or abdominal pain, and
/or loss of appetite. If you think you are experiencing any of these symptoms
you should stop taking black cohosh immediately and seek medical advice.
Anyone who has previously experienced any liver complaint or any other
serious health complaint is advised not to take black cohosh without speaking to
their doctor first. It is important to discuss all of the medication you
are taking, including herbal products, with your doctor or herbal practitioner
to ensure you receive the appropriate care.
Further information is available in the following questions and answers
document:
›
Black cohosh and liver injury: Questions and Answers [ PDF format ].
The European Medicines Agency (EMEA) has issued the following
statement:
›
Public Statement on Herbal Medicinal Products containing Cimicifugae Racemosae Rhizoma (Black Cohosh, Root) [ PDF format ].
The text in this article was prepared by the Medicines and Healthcare Products Regulatory Agency (U.K.).